Answers are grounded in this paper and cite their sources.
As of the early 1980s, despite the wealth of evidence from experimental animal models, the extensive epidemiologic evidence, the powerful genetic evidence, and the strongly suggestive clinical intervention trial results, most clinicians still remained unpersuaded regarding the relevance of the lipid hypothesis. What was needed was a well-designed, large-scale, long-term, double-blind study demonstrating a statistically significant impact of treatment on coronary heart disease events. The National Institutes of Health (NIH) had laid the groundwork for such a study as early as 1970, but the study was not completed and the results published until 1984. This study, the Coronary Primary Prevention Trial, showed that treatment with a bile acid binding resin reduced major coronary events in hypercholesterolemic men by 19%, with a P value of 0.05. The NIH followed this up with a national Consensus Development Conference on Lowering Blood Cholesterol to Prevent Heart Disease. For the first time, the NIH now went on record advocating screening for hypercholesterolemia and urging aggressive treatment for those at high risk. The Institute initiated a national cooperative program to that end, the National Cholesterol Education Program. For the first time, preventing coronary heart disease became a national public health goal. As of the early 1980s, despite the wealth of evidence from experimental animal models, the extensive epidemiologic evidence, the powerful genetic evidence, and the strongly suggestive clinical intervention trial results, most clinicians still remained unpersuaded regarding the relevance of the lipid hypothesis. What was needed was a well-designed, large-scale, long-term, double-blind study demonstrating a statistically significant impact of treatment on coronary heart disease events. The National Institutes of Health (NIH) had laid the groundwork for such a study as early as 1970, but the study was not completed and the results published until 1984. This study, the Coronary Primary Prevention Trial, showed that treatment with a bile acid binding resin reduced major coronary events in hypercholesterolemic men by 19%, with a P value of 0.05. The NIH followed this up with a national Consensus Development Conference on Lowering Blood Cholesterol to Prevent Heart Disease. For the first time, the NIH now went on record advocating screening for hypercholesterolemia and urging aggressive treatment for those at high risk. The Institute initiated a national cooperative program to that end, the National Cholesterol Education Program. For the first time, preventing coronary heart disease became a national public health goal. As early as 1970, many of the country's experts in atherosclerosis and preventive cardiology, and the American Heart Association, were already convinced that there was a causal connection between blood cholesterol and coronary heart disease, as discussed in the earlier installments of this series (1Steinberg D. An interpretive history of the cholesterol controversy. Part I.J. Lipid Res. 2004; 45: 1583-1593Google Scholar, 2Steinberg D. An interpretive history of the cholesterol controversy. Part II. The early evidence linking hypercholesterolemia to coronary disease in humans.J. Lipid Res. 2005; 46: 179-190Google Scholar, 3Steinberg D. An interpretive history of the cholesterol controversy. Part III. Mechanistically defining the role of hyperlipidemia.J. Lipid Res. 2005; 46: 2037-2051Google Scholar). However, no one could be certain how firm that connection was or how much impact treatment to decrease cholesterol levels would have. As a result, almost no nonspecialists, and in fact very few practicing internists or cardiologists, were paying very much attention to their patients' high blood cholesterol levels in 1970, and coronary heart disease continued to be the number one cause of death. What to do? The National Institutes of Health (NIH) realized that launching a national program to treat high blood cholesterol levels would be enormously complex and expensive. They could not justify that expense without first having iron-clad proof that treatment would work. In any case, the medical community would have to be convinced before could be to to any treatment the evidence was the clinical intervention were What was was study, a that would the the and the medical The first the of such a study had already in The in the of evidence linking blood cholesterol to heart disease In 1970, of the National Heart and for to the on and to on how the Institute with to the of heart disease to the the was and and had published a series of in the of in to and Scholar, in to and Scholar, in to and Scholar). They a of of on cholesterol and levels the by the of and of of Scholar, The role of and in the of and the of on were still to most and there were still to be the was to was the Institute a of lipid of the that could of lipid and to be Lipid would with and and their in the of The this of of of Heart National Heart and Institute of of D. of of of of Institute of and of or the was the evidence to the of and of treatment of the However, that the evidence that such treatment would heart and by how was still went on to that the program a intervention trial to the of the treatment of hypercholesterolemia on As a of that that strongly that the of the of Lipid not until the of the trial was was that the intervention trial would be that from the of the strongly that a intervention trial be of the and a very high As the Lipid program was and with almost no of the Heart and the Lipid was to the of and was the of were in the for and were up and a or were at of of of and of D. and of of and and and of and for the trial Coronary Primary Prevention was for a was that of the Lipid would in a trial to the The to such a complex study was not would be and would of and of but had to be The on the in a on the by that the trial was in the of many went was the experimental had the was and the study a of the national the National Heart and Institute to a program that a clinical trial as a major In was with from to NIH in and and D. at and as and and National Heart and Institute was to and the that would the for the many and very The of the almost The study would be The Coronary Primary Prevention of the Lipid The would not until and The first the had to was on the of intervention D. the coronary trial of the lipid Scholar). one of would have the treatment the of would not However, was not a The of cholesterol would be and of were would almost the the up as a double-blind study would be but to and An NIH of the of had study of the of a double-blind trial in the of the National Heart of the American Heart Association, Scholar). They in and would be that could or The would and be to from a This would have a double-blind study However, that such a in would be of the in would be expensive. The double-blind was a were the The in at the were and and of was as discussed In that the lipid could be This a at the of to the of a of on and from coronary heart disease in with of the on the of the Scholar). and showed that cholesterol levels could be by a and initiated a study to this would decrease the of coronary heart this intervention would to a double-blind to major with no that there would be a was be that with program for the of hypercholesterolemia and showed that have a significant decrease in coronary heart disease events and a decrease in with lipid by reduced coronary heart disease and from the on the of the Scholar). was blood cholesterol by and had already to in men a on the and Scholar). However, was in and had with significant in and and of the would that the having a on and Scholar). to up was a acid was but not to In the at the time, and in a of could and such a was was to in the study to any the would were acid and were acid not be and the study could not be was reduced blood cholesterol by and cholesterol by D. treatment of In and and Scholar). was would be of However, was at the as a that needed to be in or and be had to be in of a significant of or as a of of the was a that would almost was and to men to this for to with on from would have to with the of and up with to the and the up for was that of a that could not be from the and the of with the and as the but with no on the of the the men were to had in the treatment or the of the men as by They could not the many with from and lipid on a and a was to the of The study would of with no history of coronary heart disease and no of However, men would be at high of blood cholesterol levels of or with cholesterol levels in the for this men this and to for a of but to be a The was that would community to the from their In clinical and blood would be to blood cholesterol was were not cholesterol and the number of blood was much had The had for of the in the study, of the had and on the men a already had coronary heart disease and were not for the cholesterol levels were not there was no to was a of a in the to the to the of the or were to be became that the would have to to public was to be to and blood cholesterol levels in a The Lipid in the The and the the of a public firm to their This firm public for and the to in and blood from The firm to were up at and The was a cholesterol and there were a number of Lipid screening almost before the was almost men had to be the from to before the of was of the men in this study had high cholesterol levels and the lipid were at high of having a heart This the to such intervention of would be to the The would be a the lipid the time, the lipid was still a in the of In at the time, the for this had with their would have no treatment at at would have was to have a such as their have was that would cholesterol by This would the study by the in cholesterol levels between the and the of the However, on the clinical at the time, at was to decrease cholesterol levels by would be to a the reduced the cholesterol in In any case, treatment was to be for not were already to with very high cholesterol the very the was not a trial of the lipid but was a trial for those had had with in were a of the the trial would from their However, were to their to the that the trial was of The at the NIH in was by and by the trial and of the by the and the of clinical trial was a complex and a of The at was to many of the trial were in the program of a of the with this The to but of for was most of the men could their and in that the results were was as discussed the study to be statistically and the in the had the to that was and the of this trial or not the NIH would the cholesterol as a cause of was that the results would be with a by the cholesterol was to be of the of for a certain of between the and the trial on the The the of the on to the that from and a the time, the trial and for at the for the the the had followed for of The of cholesterol with much had a in cholesterol and a in the number of events coronary heart disease heart was in the with a P value of statistically significant Coronary Primary Prevention Lipid Coronary Primary Prevention II. The of in of coronary heart disease to cholesterol Scholar). was a The to the early as not In the for a a treatment that have the of a of lipid Scholar). However, was not as a was as a of cholesterol levels to the lipid hypothesis. the of the was In any case, the results of the were by the and significant in of by and of a by that the published results were to the for such on of the men without to had or had not the of In a number of the men that could not the and of the of the with but reduced the number of from the to as few as or the men were a of would to until the of the would the number of that had the the first the have was the of the study had to This for the between the in cholesterol levels and the much decrease the for those men had the of were was that had a decrease in cholesterol and a in For the study as a the in was to the in cholesterol as by the lipid hypothesis. the and the decrease in cholesterol the study had The between the decrease of cholesterol and the in the of coronary events was with the results in intervention This was despite the fact that the and and and The in the for the in the Coronary Coronary Coronary to of with to in there was The the in events in the trial of in the treatment of heart study by a of of the Scholar). The but by no that no the the of was the to cholesterol levels were the would to the of this and of those have to The of cholesterol was in the and the in was at to the of the to the was of the clinical trial results and the trial results that the for the but that the of the be to the decrease in cholesterol levels to Cholesterol clinical impact of Scholar). was in the Lipid the men had and the were with their to the in of the men had for in a very with a and The major medical the the results of the trial as the for The of a by lipid The lipid Scholar). with a and to the and of a by disease proof of the Coronary disease proof of the Scholar). the most the for the and coronary heart and coronary heart Res. Scholar). However, with that results to men with very high cholesterol that there was no that would be of and that the study to the were of at of had this to the have this the study that cholesterol the of coronary They have the or the at NIH have to this trial in the the Coronary heart the Scholar). the in the showed and heart there was no decrease in the treatment from the of preventing heart of This was the most of the and had to be However, most that this was the there was no statistically significant in was in the but that was not the number of would have had to be before one could have to a statistically significant decrease in there was no statistically significant in from any disease or disease or the of blood cholesterol were would be to up as in one or a few but that was not the of the were to and the were almost in the was of the of in the that were not as and the was not statistically but the was to be in the but in the of to was in a study to decrease cholesterol levels Heart trial with in men with of in and of coronary heart Scholar). was that any intervention that blood cholesterol levels of in the and in this to cholesterol in Scholar, cholesterol in aggressive a Scholar). and to and in of the of the in and a that there was no evidence to such hypothesis. of the cholesterol levels in the were not at their The one in the was not the but the and by a or cholesterol a with of and would that cholesterol levels coronary events and trial of cholesterol in with coronary heart the Scholar, with in of events and with in with coronary heart disease and a of cholesterol Scholar, Heart Heart of cholesterol with in a but that was not in 1984. cholesterol levels was to a national public health of be a have had to be The men of had high cholesterol would have to be the to the with the of evidence from earlier to of the the results of the in the NIH needed to As one lipid was to treat cholesterol to treat cholesterol Scholar). were that blood cholesterol was levels for not by the Lipid trial was cholesterol levels to a by by treatment would a decrease in events. This the decrease in in this study was to that in the early but could not be What were the treatment be In men and What a national would on the to there were a would the NIH be to The NIH had before a on how to with in the very The NIH had a for such the Consensus Development in of the Lipid of the and would and a Consensus Development Conference on Lowering Blood Cholesterol to Prevent Heart Disease. As with such NIH one of the Institutes such a Conference but the for and the of experts in NIH the of of of the in and in This in the Consensus Development as of as the and there be a for a the of of to and the had and had on to the be to record of the of how this was and by the of the and the of their were by Consensus or on coronary heart Scholar, Heart Scholar, The cholesterol Scholar). Conference followed the to such NIH Consensus Development was up of and the of of of the of and of the to be the of that be on the and a The of of with the of of at the was by The with the to the to be and to the experts to on the The and for a in at the to the and at this by experts not on the Consensus The and to health and and the and in the The to be by were as the between blood cholesterol levels and coronary heart disease of blood cholesterol levels coronary heart and at of blood cholesterol or treatment be be to the blood cholesterol levels of the What be on the between blood cholesterol and coronary heart experts were to the and They a of cardiology, and preventive and have significant and had on the one was a of the American Heart Association, and one was a public Consensus Development were of public of at and of the American Heart of of of D. of of of of of and of the and of was in with the to of the for one or of the would have to before the Conference was for at the NIH in The was the was and without the were in their The and the of the on the at The program was as from and animal of of and genetic how cholesterol and of of Health from and epidemiologic and of Health and blood cholesterol heart of the of and of of results from and intervention in from the Lipid of clinical trial to epidemiologic of of of of cholesterol and the of cholesterol of of and of and of and and for of Health cholesterol from of Health of and of of and of with of of and for of of of the cholesterol levels for the American public at of of and of with of and of and of of public health to American to blood and of of of of this of public health to American The role of public regarding cholesterol and heart role of the The and be on the between blood cholesterol and heart of of be to the to that the were and there was from the from that have first of the of with of the or intervention at the that of the were there was a statistically significant decrease in coronary heart disease blood cholesterol was the to be for the intervention This of results from in a on the of the intervention and had on the there was for those had strongly regarding the lipid to their and of that of the were by with to and the not their on the of the results As by the there was already of evidence of that the lipid hypothesis. The the in to the results as the in of evidence the lipid hypothesis. The Consensus Conference with as a in on a at on the to work. were still at the program in the and with a for until The had and until to on the and from for at were at the and to on the public health of the until went and now had to to had to have a or to for the at the very first there was on the first blood cholesterol and heart the of the were to of a high of blood cholesterol and how be that the cholesterol levels in the were much high and that a of for However, had to be that be a to up many and there were many to in the practicing to would up with a of that levels of for for those to and for those and the for men and few the National Cholesterol Education discussed would but of the National Cholesterol Education on and of Blood Cholesterol in Scholar). The was to much up with very much those by the American Heart Association, to and to decrease from to from and cholesterol to the of the there be a national of the major medical and public health to and the public on the of cholesterol program was the as the National Cholesterol Education Program. As discussed the of a for and on to and The National Cholesterol Education and Scholar, National Cholesterol Education Program. and Scholar). The of the Consensus Conference was published in the of the American and in major at the of and the was a or the and the had cholesterol that were in and treatment the Cholesterol were by no The most the Consensus but the published was as much or on the of of a of as on the of the and the by the of the from the the in this have to have and in the by the a number of in the the that This the and to be in the in and much the be in a In the of any for convinced to that their the The from was and was by experts that the of the Consensus were have that was with that had and to What not that the that with the a of the experts in the of the time, have no of of the They be to their or of the experts for a In this case, such a had already and the results published in was not much attention and the was of of the of a to there was a experts on atherosclerosis with to the role of blood cholesterol and of coronary heart Scholar). a to and on and The almost in the at the of those the results were In to the there a connection between cholesterol and the of coronary heart of those and were the that and coronary heart disease to a in the for the in of those and was was that not the many of the but showed that before the NIH Consensus of the experts in the the evidence linking blood cholesterol to heart already very to that their to and decrease their blood a decrease in and a decrease in the Consensus Conference was of the of the but that to The that the have the that experts or on the and that In this case, there were to the or not have to with the were but In of the experts and of The from was much to the of the not for a from the of the and one from on of the of of but had already few the Consensus published in The a or on coronary heart Consensus or on coronary heart Scholar). of to experts levels of blood cholesterol in the high and be and still a major in had in many to coronary heart disease and needed to be how the how to strongly In published to in The that the of experts and that were no a to with the of the was and had from the as in the and few the Consensus The published and on by cholesterol The cholesterol Scholar). a have by the on not by the heart but by a that a medical of the This heart National and Blood the American Heart went on to very in the lipid at the had to to the had by for clinical and followed a series of this of and the that that one to such that their were in by from no to the and of any of the cholesterol of The of or not cholesterol levels would coronary was one the and had already with to For the this was a very for on the that were and cholesterol the first evidence that the cholesterol reduced the of clinical were for the to be in this of the in the Coronary and had not to but had Coronary Coronary to of with to Scholar). in extensive clinical in had reduced but had to be of the and had by the for cholesterol but to have and and was from the The The of and Scholar). at were by a but number of were of of this of there was in the or at the for to treat acid and were already on the in but the not cholesterol acid was for as a for as a and was to be in the of many were to decrease blood cholesterol but were was not until the that the that the evidence linking blood cholesterol levels to coronary disease was to justify the of without the to at the of clinical trial demonstrating to of the of and at the up for the results of the Lipid and the of the Consensus Conference very in the of such a and the for the of the now with the results of the and a the in the the NIH to high for the first the to blood cholesterol levels a goal. would be and but would be the and the in the the by for a national cooperative program to health and the the National Cholesterol Education was that from national health the American Association, the American Health Association, the American Heart Association, and from This was to be a and was to be on the was in of the program and continued to and to this The National Cholesterol Education and Scholar, National Cholesterol Education Program. and Scholar). of the impact of the program the in by of the of high cholesterol The of cholesterol at would from in to in and the of as a very for heart disease from to the and the and as but the a role in this in the most of the was to for and of cholesterol or would intervention be levels would the of be This a of and The in be to have of the at their They They from experts have the on such The on the for those the very a was to the of the Consensus defining at or be and treatment In the first published of the National Cholesterol Education on and of Blood Cholesterol in became the on to treat and how to followed the and to their for in were to those of the have of the and in and The to in the of heart and their their to the of were there was that blood cholesterol was a significant in coronary heart disease and a national program was in to the was not remained would heart and from heart but would were the of blood there any in there any in the from treatment to not were not in but would be in the was to the of the for cholesterol as discussed in the and of this The and at the NIH for the the Consensus and the of the of for the of the Consensus and for and on the of the early intervention trial of and at the and in that for and on and for the and for and on the
No takes yet. Share an insight, caveat, or question.
Daniel Steinberg (2005) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: